INCIDENTAL PUBLIC EXPOSE OF PT PYRIDAM FARMA TBK
The Board of Directors of PT Pyridam Farma Tbk., (hereinafter referred to as the “Company”) domiciled in South Jakarta, hereby
PYFAGROUP’s Commitment to the Nation’s Health is Realized Through the Expansion of Ethica Industri Farmasi’s Injection Production Facility
Jakarta, September 12, 2024 – PT Ethica Industri Farmasi, a pharmaceutical company under the PYFAGROUP, has officially commenced the groundbreaking
Change of Corporate Secretary of PT Pyridam Farma Tbk.
Pursuant to Financial Service Authority Regulation No. 35/POJK.04/2014 regarding Corporate Secretary of Issuer or Public Company and based on Decree of the Board
PYFAGROUP Becomes the First to Launch CDMO Services in the Global Pharmaceutical Industry
Jakarta, August 9, 2024 – Anticipating the rapid growth of the health product market, PYFAGROUP, comprising leading pharmaceutical companies Pyridam
Pyridam Farma Acquires Major Australian Pharmaceutical Company, Expands into Global Market.
Jakarta, August 9, 2024 – Anticipating the rapid growth of the health product market, PYFAGROUP, comprising leading pharmaceutical companies Pyridam
PYFAESTHETIC Successfully Holds Soft Launching of Carboxy Therapy in Jakarta and Surabaya
Jakarta, 11 June 2024 – PYFAESTHETIC, a business unit of PT Pyridam Farma Tbk, has successfully held a soft launch
PYFAESTHETIC Holds Another Cadaver Training in Manila
Jakarta, June 5, 2024 – PYFAESTHETIC, a subsidiary of PT Pyridam Farma Tbk (PYFA) engaged in dermatology and aesthetics, has
Pyridam Farma and Medomics Launch Innovative Rapid Test for Vulvovaginitis Diagnosis
Jakarta, June 3, 2024 – Vulvovaginitis is a common gynecological condition affecting women of reproductive age. Symptoms often include vaginal
Pyridam Farma Distributes Osteoporosis Medication from EffRx Pharmaceuticals Swiss
Jakarta, May 2, 2024 – EffRx Pharmaceuticals SA, a Swiss pharmaceutical company focused on developing and commercializing musculoskeletal and rare